{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:25:43Z","timestamp":1793291143660,"version":"4.5.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32HL110837"],"award-info":[{"award-number":["T32HL110837"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006775","name":"GE Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011949","name":"Abbott Vascular","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004324","name":"Astellas Pharma US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Imaging"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.jcmg.2019.04.020","type":"journal-article","created":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T14:00:03Z","timestamp":1563372003000},"page":"1821-1831","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Randomized Comparison of Clinical Effectiveness of Pharmacologic SPECT and PET MPI in Symptomatic CAD Patients"],"prefix":"10.1016","volume":"12","author":[{"given":"Krishna K.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firas","family":"Al Badarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul S.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Spertus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Staci","family":"Courter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin F.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Case","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Iain","family":"McGhie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary V.","family":"Heller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M.","family":"Bateman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmg.2019.04.020_bib1","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1016\/j.jacc.2012.07.012","volume":"60","author":"Fihn","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2019.04.020_bib2","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jacc.2013.11.009","volume":"63","author":"Wolk","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2019.04.020_bib3","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1053\/j.semnuclmed.2014.05.003","article-title":"Cardiac PET perfusion: prognosis, risk stratification, and clinical management","volume":"44","author":"Dorbala","year":"2014","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.jcmg.2019.04.020_bib4","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s11886-014-0472-9","article-title":"Assessing the prognostic implications of myocardial perfusion studies: identification of patients at risk vs patients who may benefit from intervention?","volume":"16","author":"Cremer","year":"2014","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.jcmg.2019.04.020_bib5","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.2967\/jnumed.116.180448","article-title":"American Society of Nuclear Cardiology and Society of Nuclear Medicine and Molecular Imaging joint position statement on the clinical indications for myocardial perfusion PET","volume":"57","author":"Bateman","year":"2016","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jcmg.2019.04.020_bib6","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1001\/jamacardio.2017.2471","article-title":"Comparison of coronary CT angiography, SPECT, PET, and Hybrid imaging for diagnosis of ischemic heart disease determined by fractional flow reserve","volume":"2","author":"Danad","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jcmg.2019.04.020_bib7","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jacc.2011.09.066","article-title":"Patient management after noninvasive cardiac imaging results from SPARC (study of myocardial perfusion and coronary anatomy imaging roles in coronary artery disease)","volume":"59","author":"Hachamovitch","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2019.04.020_bib8","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005628","article-title":"Temporal trends of single-photon emission computed tomography myocardial perfusion imaging in patients with coronary artery disease: a 22-year experience from a tertiary academic medical center","author":"Jouni","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2019.04.020_bib10","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s12350-016-0522-3","article-title":"ASNC imaging guidelines\/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures","volume":"23","author":"Dilsizian","year":"2016","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.jcmg.2019.04.020_bib11","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.jacc.2003.07.010","article-title":"Transient ischemic dilation ratio of the left ventricle is a significant predictor of future cardiac events in patients with otherwise normal myocardial perfusion SPECT","volume":"42","author":"Abidov","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2019.04.020_bib12","first-page":"349","article-title":"Value of vasodilator left ventricular ejection fraction reserve in evaluating the magnitude of myocardium at risk and the extent of angiographic coronary artery disease: a 82Rb PET\/CT study","volume":"48","author":"Dorbala","year":"2007","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jcmg.2019.04.020_bib13","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.jcmg.2009.04.009","article-title":"Incremental prognostic value of gated Rb-82 positron emission tomography myocardial perfusion imaging over clinical variables and rest LVEF","volume":"2","author":"Dorbala","year":"2009","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jcmg.2019.04.020_bib14","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0735-1097(94)00397-9","article-title":"Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease","volume":"25","author":"Spertus","year":"1995","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2019.04.020_bib15","first-page":"1","article-title":"Cardiovascular survey methods","volume":"56","author":"Rose","year":"1968","journal-title":"Monogr Ser World Health Organ"},{"key":"10.1016\/j.jcmg.2019.04.020_bib16","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.ahj.2009.03.021","article-title":"The impact of dyspnea on health-related quality of life in patients with coronary artery disease: results from the PREMIER registry","volume":"157","author":"Arnold","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcmg.2019.04.020_bib17","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.2967\/jnumed.106.038323","article-title":"Impact of myocardial perfusion imaging with PET and (82)Rb on downstream invasive procedure utilization, costs, and outcomes in coronary disease management","volume":"48","author":"Merhige","year":"2007","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jcmg.2019.04.020_bib18","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/CIRCIMAGING.112.978270","article-title":"Diagnostic accuracy of cardiac positron emission tomography versus single photon emission computed tomography for coronary artery disease: a bivariate meta-analysis","volume":"5","author":"Parker","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2019.04.020_bib19","first-page":"450","article-title":"Diagnostic accuracy of stress myocardial perfusion imaging compared to invasive coronary angiography with fractional flow reserve meta-analysis","volume":"10","author":"Takx","year":"2016","journal-title":"Circ Cardiovasc Imaging"}],"container-title":["JACC: Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936878X1930542X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936878X1930542X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T16:22:49Z","timestamp":1773246169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936878X1930542X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":18,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1936878X1930542X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmg.2019.04.020","relation":{},"ISSN":["1936-878X"],"issn-type":[{"value":"1936-878X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized Comparison of Clinical Effectiveness of Pharmacologic SPECT and PET MPI in Symptomatic CAD Patients","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmg.2019.04.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}